Chongqing Huapont Pharm. Co., Ltd operates in the Pharmaceutical preparations sector. Chongqing Huapont Pharm. Co., Ltd is principally engaged in the manufacture and sale of pharmaceutical products. The Company primarily offers three categories of medicines: medicines for treating skin diseases, including levocetirizine dihydrochloride tablets, acitretin capsules, naftifine hydrochloride and ketoconazole cream, compound alazopeptin tablets, viaminate capsules, tretinoin cream, viaminate and vitamin E cream; antitubercular agents, including isoniazid aminosalicylate tablets and rifampicin for injection, and antineoplastic drugs, such as anastrozole tablets. The Company is also involved in the provision of tourism services. The Company distributes its products within domestic market and to overseas markets. In our complete report available for purchase the company is compared to: Biostar Pharmaceuticals Incorporation, Sinovac Biotech Ltd and Xiangxue Pharmaceutical Co Ltd.